Terumo Neuro Launches SOFIA™ 88 Catheter Data Highlighting Outstanding Stroke Performance Terumo Neuro unveils new data on the SOFIA™ 88 catheter, showcasing superior performance in stroke treatment compared to other super-bore catheters.

Terumo Neuro Launches SOFIA™ 88 Catheter Data Highlighting Outstanding Stroke Performance #United_States #Nashville #Stroke_Treatment #Terumo_Neuro #SOFIA™_88

Terumo Neuro Launches SOFIA™ Flow 88 Catheter for Stroke Treatment in EMEA Terumo Neuro announces the commercial launch of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter, enhancing stroke treatment in EMEA with improved reliability and flexibility.

Terumo Neuro Launches SOFIA™ Flow 88 Catheter for Stroke Treatment in EMEA #USA #California #Stroke_Treatment #Terumo_Neuro #SOFIA_Flow_88

Terumo Neuro Launches New SOFIA™ Flow 88 Catheter for Stroke Care in EMEA Region Terumo Neuro reveals the SOFIA™ Flow 88 Neurovascular Aspiration Catheter's commercial availability in EMEA, enhancing stroke treatment options.

Terumo Neuro Launches New SOFIA™ Flow 88 Catheter for Stroke Care in EMEA Region #None #Paris #Stroke_Treatment #Terumo_Neuro #SOFIA_Flow_88

Brainomix Enhances Stroke Treatment with Cutting-Edge AI Technology at ESOC Conference Brainomix showcases breakthrough AI imaging findings at the ESOC conference in Helsinki, enhancing stroke treatment accessibility and efficacy across networks.

Brainomix Enhances Stroke Treatment with Cutting-Edge AI Technology at ESOC Conference #United_Kingdom #Oxford #Brainomix #AI_Imaging #Stroke_Treatment

Brainomix Secures £14M Series C Funding to Enhance AI Imaging Technology in Healthcare Brainomix has completed a £14M Series C funding round to expand its AI imaging solutions for stroke and lung fibrosis, enhancing patient care.

Brainomix Secures £14M Series C Funding to Enhance AI Imaging Technology in Healthcare #United_Kingdom #Oxford #Brainomix #Stroke_Treatment #AI_Imaging_Technology

Remedy Pharmaceuticals Receives Significant Patent Allowance for CIRARA in Stroke Treatment Remedy Pharmaceuticals has gained significant patent permits for CIRARA, enhancing treatment options for large hemispheric infarctions and wake-up strokes.

Remedy Pharmaceuticals Receives Significant Patent Allowance for CIRARA in Stroke Treatment #United_States #New_York #Stroke_Treatment #Remedy_Pharmaceuticals #CIRARA

Remedy Pharmaceuticals Reveals Breakthrough Stroke Treatment Data at International Stroke Conference 2025 At the ISC 2025, Remedy Pharmaceuticals shared promising data from studies on CIRARA, showing marked improvements in stroke recovery outcomes.

Remedy Pharmaceuticals Reveals Breakthrough Stroke Treatment Data at International Stroke Conference 2025 #USA #New_York #Stroke_Treatment #Remedy_Pharmaceuticals #CIRARA

Groundbreaking Findings at the International Stroke Conference Highlight Brainomix 360 Innovations New studies at the International Stroke Conference reveal how Brainomix 360 is transforming stroke treatment, enhancing patient outcomes through advanced AI imaging.

Groundbreaking Findings at the International Stroke Conference Highlight Brainomix 360 Innovations #United_Kingdom #Oxford #AI_Imaging #Stroke_Treatment #Brainomix_360

Remedy Pharmaceuticals to Present Efficacy Data for CIRARA at 2025 International Stroke Conference Remedy Pharmaceuticals will unveil compelling data on CIRARA at the ISC 2025, showcasing its potential for improving outcomes in Large Hemispheric Infarction patients.

Remedy Pharmaceuticals to Present Efficacy Data for CIRARA at 2025 International Stroke Conference #United_States #Los_Angeles #Stroke_Treatment #Remedy_Pharmaceuticals #CIRARA

Simcere's Sanbexin® Sublingual Tablets Approved for Acute Ischemic Stroke Treatment Simcere Pharmaceutical's Sanbexin® sublingual tablets have received Chinese approval for treating acute ischemic stroke, promising significant improvements in recovery.

Simcere's Sanbexin® Sublingual Tablets Approved for Acute Ischemic Stroke Treatment #China #Nanjing #Simcere #Sanbexin #Stroke_Treatment